IBDEI2FA ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41094,1,4,0)
 ;;=4^N32.0
 ;;^UTILITY(U,$J,358.3,41094,2)
 ;;=^5015649
 ;;^UTILITY(U,$J,358.3,41095,0)
 ;;=N31.9^^159^2000^70
 ;;^UTILITY(U,$J,358.3,41095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41095,1,3,0)
 ;;=3^Neurogenic Bladder Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,41095,1,4,0)
 ;;=4^N31.9
 ;;^UTILITY(U,$J,358.3,41095,2)
 ;;=^5015648
 ;;^UTILITY(U,$J,358.3,41096,0)
 ;;=N31.1^^159^2000^71
 ;;^UTILITY(U,$J,358.3,41096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41096,1,3,0)
 ;;=3^Neuropathic Bladder,Reflex NEC
 ;;^UTILITY(U,$J,358.3,41096,1,4,0)
 ;;=4^N31.1
 ;;^UTILITY(U,$J,358.3,41096,2)
 ;;=^5015645
 ;;^UTILITY(U,$J,358.3,41097,0)
 ;;=N32.89^^159^2000^5
 ;;^UTILITY(U,$J,358.3,41097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41097,1,3,0)
 ;;=3^Bladder Disorders,Other Spec
 ;;^UTILITY(U,$J,358.3,41097,1,4,0)
 ;;=4^N32.89
 ;;^UTILITY(U,$J,358.3,41097,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,41098,0)
 ;;=N33.^^159^2000^4
 ;;^UTILITY(U,$J,358.3,41098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41098,1,3,0)
 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,41098,1,4,0)
 ;;=4^N33.
 ;;^UTILITY(U,$J,358.3,41098,2)
 ;;=^5015654
 ;;^UTILITY(U,$J,358.3,41099,0)
 ;;=N34.2^^159^2000^99
 ;;^UTILITY(U,$J,358.3,41099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41099,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,41099,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,41099,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,41100,0)
 ;;=N34.1^^159^2000^100
 ;;^UTILITY(U,$J,358.3,41100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41100,1,3,0)
 ;;=3^Urethritis,Nonspec
 ;;^UTILITY(U,$J,358.3,41100,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,41100,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,41101,0)
 ;;=N39.0^^159^2000^104
 ;;^UTILITY(U,$J,358.3,41101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41101,1,3,0)
 ;;=3^Urinary Tract Infection,Site Not Spec
 ;;^UTILITY(U,$J,358.3,41101,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,41101,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,41102,0)
 ;;=N31.0^^159^2000^72
 ;;^UTILITY(U,$J,358.3,41102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41102,1,3,0)
 ;;=3^Neuropathic Bladder,Uninhibited NEC
 ;;^UTILITY(U,$J,358.3,41102,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,41102,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,41103,0)
 ;;=R31.9^^159^2000^54
 ;;^UTILITY(U,$J,358.3,41103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41103,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,41103,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,41103,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,41104,0)
 ;;=R31.0^^159^2000^52
 ;;^UTILITY(U,$J,358.3,41104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41104,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,41104,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,41104,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,41105,0)
 ;;=R31.2^^159^2000^53
 ;;^UTILITY(U,$J,358.3,41105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41105,1,3,0)
 ;;=3^Hematuria,Microscopic
 ;;^UTILITY(U,$J,358.3,41105,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,41105,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,41106,0)
 ;;=R31.1^^159^2000^51
 ;;^UTILITY(U,$J,358.3,41106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41106,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,41106,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,41106,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,41107,0)
 ;;=N40.0^^159^2000^30
 ;;^UTILITY(U,$J,358.3,41107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41107,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,41107,1,4,0)
 ;;=4^N40.0
